ASCs have been an important element of Stryker’s robotic strategy, including new product launches, CEO Kevin Lobo said in an April 30 quarterly earnings call.
One notable launch Mr. Lobo discussed was the Mako Robotic Power System for total knee, which was released in a limited launch in February. He said the company is in “a very active phase” of trialing the robot with new customers.
“So far, ASCs have been a bit of a sweet spot,” Mr. Lobo said, as transcribed by Motley Fool. “I am not saying we will limit this to the ASC, but the transition to RPS is much easier for a surgeon than going all the way to Mako. In terms of how you do the procedure, it is very easy to adopt. Some competitive surgeons liked the idea of going to a robotic solution with haptic boundaries, but the move all the way to Mako was a bit too intimidating.”
Mr. Lobo also said he expects adoption of the RPS to pick up in the second half of the year.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.